Product Description
Flunisolide nasal spray is used to relieve symptoms of sneezing, runny, stuffy, or itchy nose caused by hay fever or other allergies. Flunisolide nasal spray should not be used to treat symptoms (e.g., sneezing, stuffy, runny, itchy nose) caused by the common cold. It is in a class of medications called corticosteroids. It works by blocking the release of certain natural substances that cause allergy symptoms. (Sourced from: https://medlineplus.gov/druginfo/meds/a685022.html)
Mechanisms of Action: GR Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Approved
Approved Countries: Canada | Colombia | Germany | India | Ireland | Italy | New Zealand | Pakistan | Peru | Portugal | Slovenia | United Kingdom | United States | Venezuela
Approved Indications: Asthma
Known Adverse Events: Headache | Spasm | Pharyngitis | Tuberculosis | Tuberculosis, Ocular | Tuberculosis, Oral | Tuberculosis, Renal | Cataract | Glaucoma | Rhinitis | Sinusitis | Chickenpox | Herpes Simplex | Measles
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|